# Cerezyme

NDC: 58468-4663
Generic name: IMIGLUCERASE
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 19940523

FDA application: BLA020367

## Active ingredients

- IMIGLUCERASE: 40 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-4663"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-4663
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df60f030-866b-4374-a31f-8ae3f6b45c38